The London-listed company behind the Revolution bars chain has set a deadline for bids next week after warning shareholders ...
US stocks sputtered Wednesday as Wall Street prepared to wrap up an eventful, roller-coaster trading year with sizable gains. Those losses have dimmed hopes for a so-called Santa Claus rally. But at ...
Stock prices in London closed in the red on Wednesday at the end of a shortened trading day, but the FTSE 100 index ended the ...
Pfizer (NYSE:PFE) and GlaxoSmithKline (NYSE:GSK) are among the top drugmakers planning price increases for hundreds of ...
Even as the Trump administration wants drugmakers to cut prices, the median industry raise will be about 4%, similar to last ...
EADSY lands a firm order for 30 A320neo aircraft from CALC, reinforcing strong global demand for its fuel-efficient ...
The world’s hottest (AI) stock this year wasn’t Nvidia, Microsoft, or any Silicon Valley giant. It was Kioxia Holdings, a ...
They also underscore risks for Nvidia, as Beijing has yet to approve any shipments of H200 chips. The administration of US ...
One pub shut its doors for good each day in 2025 as cost pressures continued to weigh on the sector, according to new figures ...
China's factory activity unexpectedly grew in December, snapping a record eight straight months of decline, lifted by a rise ...
The Bank of England cut interest rates to 3.75% from 4% in its final policy decision of 2025, taking borrowing costs to their ...
Comprehensive Analysis of Tirzepatide Access Options as Resolution Season Peaks: MyStart Health Programs, FDA Context, Coverage Developments, and Questions to Consider Before Starting GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results